http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-253120-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba3c09f5ae01d64e1f091f9a3ade1b03
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0495
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C63-70
filingDate 1959-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1960-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-253120-A1
titleOfInvention PROCEDURE FOR OBTAINING A NEW MEANS OF RADIOLOGICAL CONTRAST
abstract Tetra-, penta-, octa- and deca-iodo-benzoic acid amides of the general formula (I) <FORM:0881510/IV (b)/1> wherein Z is a hydrogen or an iodine atom, an amino group or an acylamino group of not more than 4 carbon atoms. Y is a methylene radical or a polymethylene radical of not more than 6 carbon atoms, a cycloalkylene radical or 5 or 6 carbon atoms, or a phenylene radical, and X is a hydrogen atom, or an alkyl, cycloalkyl, aralkyl or aryl radical, which radical may be substituted with a hydroxyl or lower alkoxy group or, in the case where X is an alkyl radical, it may be substituted with the group <FORM:0881510/IV (b)/2> are prepared by a process in which the principle step is the action of the acid chloride having the formula <FORM:0881510/IV (b)/3> on an alkyl ester of the appropriate amino carboxylic acid or diamino dicarboxylic acid. In Example 2, a solution of 3-iodo-5-amino-benzoic acid in hydrochloric acid is reacted with a solution of NaCl.Cl.I in hydrochloric acid to obtain 3-amino-2,4,5,6-tetraiodobenzoic acid, from which the corresponding acid-chloride is then obtained by treatment with thionyl chloride. In Example 7, methyl-N-beta-hydroxy-ethyl-beta1-aminopropionate is heated with 3-amino-2,4,5,6-tetraiodobenzoyl chloride yielding methyl N - (3 - amino - 2,4,5,6 - tetraiodobenzoyl) - N - beta - hydroxyethyl-beta1-aminopropionate and the example also describes the preparation of the free acid and the sodium salt. Example 3 describes the preparation of pentaiodo-benzoyl chloride by the action of thionyl chloride on pentaiodobenzoic acid. The latter is obtained by treating diazotized 3-amino-2,4,5,6-tetraiodo-benzoic acid with KI. In Example 9, pentaiodo-benzoyl chloride is heated with methyl alpha-amino-n-butyrate to give methyl N-(pentaiodo-benzoyl)-alpha-amino-n-butyrate. In Example 12, methyl hexamethylene diamine-N,N1-bis-beta-propionate is reacted with 3-amino-2,4,5,6-tetraiodobenzoyl chloride to give the dimethyl ester of hexamethylene-diamino-N,N1-bis-(3-amino - 2,4,5,6 - tetraiodobenzoyl) - N,N1 - bis - beta-propionic acid. These polyiodated benzoic acid amides are effective X-ray contrast agents (Group VI).ALSO:The invention comprises X-ray contrast compositions comprising a tetra-, penta-, octa-and deca-iodo-benzoic acid amide of the general formula <FORM:0881510/VI/1> wherein Z is a hydrogen or an iodine atom, an amino group or an acylamino group of not more than 4 carbon atoms Y is methylene radical or a polymethylene radical of not more than 6 carbon atoms, a cycloalkylene radical of 5 or 6 carbon atoms, or a phenylene radical and X is a hydrogen atom, or an alkyl, cyclo-alkyl, aralkyl or aryl radical, which radical may be substituted with an hydroxyl or lower alkoxy group or, in the case where X is an alkyl radical, it may be substituted with the group <FORM:0881510/VI/2> or a non-toxic salt of such a polyiodo-benzoic acid amide, with a non-toxic carrier therefor. Non-toxic salts specified are those of sodium, lithium, diethanolamine, and methyl glucosamine. The free acids as well as the non-toxic salts may be processed to form tablets together with binders such as starch, talc, polyethylene glycol, magnesium stearate, lauryl alcohol sulphonate, or both starch and lactic acid. The polyiodo compound may also be mixed with groundnut oil and lecithine, and filled into gelatine capsules.
priorityDate 1958-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431912795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154093785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6850739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12386001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426120399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133082317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432114263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414009360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431928075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12256098
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450136125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432378380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3028194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154314001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421907888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426591525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11555753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154174129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553

Total number of triples: 66.